HUMAN GENOME SCIENCES INC Financing Cash Flow
HUMAN GENOME SCIENCES INC reported Financing Cash Flow of $6.81 million for the 6-month period ending 2012-06-30, per its 10-Q filed 2012-07-26.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2012-07-26
- HUMAN GENOME SCIENCES INC net cash provided by (used in) financing activities for the quarter ending 2012-06-30 was $6.06M, a 28.90% decline year-over-year.
- HUMAN GENOME SCIENCES INC net cash provided by (used in) financing activities for the quarter ending 2012-03-31 was $743.00K, a 81.22% decline year-over-year.
- HUMAN GENOME SCIENCES INC net cash provided by (used in) financing activities for the quarter ending 2011-12-31 was $350.98M, a 14690.56% increase year-over-year.
- HUMAN GENOME SCIENCES INC net cash provided by (used in) financing activities for the quarter ending 2011-09-30 was $3.47M, a 36.45% decline year-over-year.
- HUMAN GENOME SCIENCES INC net cash provided by (used in) financing activities for fiscal 2011 was $366.94M, a 901.11% increase from fiscal 2010.
- HUMAN GENOME SCIENCES INC net cash provided by (used in) financing activities for fiscal 2010 was $36.65M, a 95.37% decline from fiscal 2009.
- HUMAN GENOME SCIENCES INC net cash provided by (used in) financing activities for fiscal 2009 was $790.98M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2012-06-30 | $6.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-26 | $6.81M 10-Q · filed 2012-07-26 | $357.79M derived: sum of 3 quarters · filed 2012-07-26 | $361.26M derived: sum of 4 quarters · filed 2012-07-26 |
| 2012-03-31 | $743.00K 10-Q · filed 2012-04-26 | $351.72M derived: sum of 2 quarters · filed 2012-04-26 | $355.20M derived: sum of 3 quarters · filed 2012-04-26 | $363.72M derived: sum of 4 quarters · filed 2012-07-26 |
| 2011-12-31 | $350.98M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $354.45M derived: sum of 2 quarters · filed 2012-02-28 | $362.98M derived: sum of 3 quarters · filed 2012-07-26 | $366.94M 10-K · filed 2012-02-28 |
| 2011-09-30 | $3.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28 | $12.00M derived: sum of 2 quarters · filed 2012-07-26 | $15.96M 10-Q · filed 2011-10-28 | $18.33M derived: sum of 4 quarters · filed 2012-07-26 |
| 2011-06-30 | $8.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-26 | $12.48M 10-Q · filed 2012-07-26 | $14.86M derived: sum of 3 quarters · filed 2012-07-26 | $20.32M derived: sum of 4 quarters · filed 2012-07-26 |
| 2011-03-31 | $3.96M 10-Q · filed 2012-04-26 | $6.33M derived: sum of 2 quarters · filed 2012-04-26 | $11.79M derived: sum of 3 quarters · filed 2012-04-26 | $20.22M derived: sum of 4 quarters · filed 2012-04-26 |
| 2010-12-31 | $2.37M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $7.84M derived: sum of 2 quarters · filed 2012-02-28 | $16.27M derived: sum of 3 quarters · filed 2012-02-28 | $36.65M 10-K · filed 2012-02-28 |
| 2010-09-30 | $5.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28 | $13.89M derived: sum of 2 quarters · filed 2011-10-28 | $34.28M 10-Q · filed 2011-10-28 | |
| 2010-06-30 | $8.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-28 | $28.82M 10-Q · filed 2011-07-28 | ||
| 2010-03-31 | $20.39M 10-Q · filed 2011-04-29 | |||
| 2009-12-31 | $790.98M 10-K · filed 2012-02-28 |